Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th

Updated on: February 23,2024

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th

Updated on:February 23,2024

Vitamin A derivative selectively kills liver cancer stem cells

by RIKENRetinol or Vitamin A 3D space model (balls model). Credit: YassineMrabet, Wikipedia.Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurren

Updated on: March 06,2024

Vitamin A derivative selectively kills liver cancer stem cells

by RIKENRetinol or Vitamin A 3D space model (balls model). Credit: YassineMrabet, Wikipedia.Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurren

Updated on:March 06,2024

Novel liquid biopsy methodology enables monitoring of disease evolution in patients with metastatic prostate cancer

byVall d'Hebron Institute of OncologyGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.003Published today inCancer Cell, results of astudy&nb

Updated on: July 09,2024

Novel liquid biopsy methodology enables monitoring of disease evolution in patients with metastatic prostate cancer

byVall d'Hebron Institute of OncologyGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.003Published today inCancer Cell, results of astudy&nb

Updated on:July 09,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on: March 30,2024

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on:March 30,2024

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Updated on: November 09,2024

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Updated on:November 09,2024

Fighting liver cancer takes big financial toll: Study

by Cara MurezOut-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis withhepatoc

Updated on: January 16,2024

Fighting liver cancer takes big financial toll: Study

by Cara MurezOut-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis withhepatoc

Updated on:January 16,2024

New imaging method superior for diagnosing multiple types of cancer, with potential for targeted treatment

bySociety of Nuclear MedicineOptimization of the specific activities of111In-FAP6-IP-DOTA in HT29 tumors over time as a function of molar amount of FAP6 conjugate injected while maintainin

Updated on: January 11,2024

New imaging method superior for diagnosing multiple types of cancer, with potential for targeted treatment

bySociety of Nuclear MedicineOptimization of the specific activities of111In-FAP6-IP-DOTA in HT29 tumors over time as a function of molar amount of FAP6 conjugate injected while maintainin

Updated on:January 11,2024

Prostate cancer testing in Sweden—a study on cost and effectiveness

byKarolinska InstitutetShuang Hao, PhD student at the Department of Medical Epidemiology and Biostatistics. Credit: Stefan ZimmermanProstate cancer constitutes an essential public health issue,

Updated on: January 03,2024

Prostate cancer testing in Sweden—a study on cost and effectiveness

byKarolinska InstitutetShuang Hao, PhD student at the Department of Medical Epidemiology and Biostatistics. Credit: Stefan ZimmermanProstate cancer constitutes an essential public health issue,

Updated on:January 03,2024

Eliminating senescent cells could help treat breast, pancreatic cancers

byWashington University in St. LouisShown is a human breast tumor sample. The white arrows point to senescent cells in the tumor. Eliminating senescent cells, which drive inflammation, could bec

Updated on: August 03,2024

Eliminating senescent cells could help treat breast, pancreatic cancers

byWashington University in St. LouisShown is a human breast tumor sample. The white arrows point to senescent cells in the tumor. Eliminating senescent cells, which drive inflammation, could bec

Updated on:August 03,2024

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou

Updated on: May 17,2024

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou

Updated on:May 17,2024

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Updated on: March 12,2024

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Updated on:March 12,2024

Biology behind new drug used to treat triple-negative breast cancer uncovered

by Georgetown University Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainHow TTP488 (azeliragon), an experimental drug, impairs aggr

Updated on: January 28,2024

Biology behind new drug used to treat triple-negative breast cancer uncovered

by Georgetown University Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainHow TTP488 (azeliragon), an experimental drug, impairs aggr

Updated on:January 28,2024